Page results
-
Tens of thousands of babies hospitalised across the UK each year could now be protected by a new maternal Respiratory syncytial virus (RSV) vaccine available from today to protect babies
-
UCLH Charity’s magazine, Charity Matters is out now.
-
UCLH has formed a partnership with the Business Design Centre in Islington to deliver a second COVID-19 large scale vaccination centre.
-
As part of Our National Health Stories, University College London Hospitals NHS Foundation Trust commissioned five poets to write and share stories from the NHS.
-
Contact the UCLH Media and Communications team. Read the UCLH magazine.
-
Contact details of clinical lead adults and lead paediatrics
-
The Hyperacute Stroke Unit (HASU) and the Transient Ischaemic Attack (TIA) services were relocated from the seventh floor of University College Hospital to The National Hospital for Neurology and Neurosurgery (NHNN) on 20 March 2020 as part of UCLH’s response to the Covid-19 pandemic.
-
Information for the Camden Sickle Cell and Thalassaemia Service
-
Achilles Therapeutics, a company built on research at UCLH, UCL Cancer Institute and the Francis Crick Institute has successfully raised $175.5 million through its initial public offering in the United States.
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
File results
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis
-
FOI/2023/0840 - Deaths in accident and emergency 2018-2023
-
FOI/2023/0842 - Acquired Brain Injury condition daily fees/ spend per patient
-
FOI/2023/0845 - Treatement for gastric and gastro-oesophageal junction/ Oesophageal/ ovarian cancers
-
FOI/2023/0849 - Physician Associates
-
FOI/2023/0870 - Cancer treatments cancelled or rescheduled
-
FOI/2023/0874 - Telecommunication infrastructure
-
FOI/2023/0875 - Treatment for bladder cancer